Author:
Takashina Ken,Bessho Tomoko,Mori Reiko,Kawai Kunji,Eguchi Junichi,Saito Ken-Ichi
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference35 articles.
1. Aarsland D, Mosimann UP, McKeith IG (2004) Role of cholinesterase inhibitors in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:164–171
2. Abdiche YN, Myszka DG (2004) Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal Biochem 328:233–243
3. Bessho T, Takashina K, Tabata R, Oshima C, Chaki H, Yamabe H, Egawa M, Tobe A, Saito K-I (1996) Effects of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro[2, 3-b]quinolin-4-yl) acetoamide on deficits of water maze learning in rats. Arzneimittelforschung 46:369–373
4. Bessho T, Takashina K, Eguchi J, Komatsu T, Saito K-I (2008) MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats. J Neural Transm. doi: 10.1007/s00702-008-0053-4
5. Chrobak JJ, Hanin I, Schmechel TJ, Walsh TJ (1988) AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res 463:107–117
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献